Generation Bio Co. (GBIO) Financials
GBIO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 374.8 million | 171.6 million |
| 2023-09-30 | 381.5 million | 149.6 million |
| 2023-06-30 | 404.9 million | 150.6 million |
| 2023-03-31 | 431.4 million | 152.3 million |
GBIO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -29.6 million | 6.0 million |
| 2023-09-30 | -25.5 million | 6.0 million |
| 2023-06-30 | 23.4 million | 6.0 million |
| 2023-03-31 | -28.4 million | 6.3 million |
GBIO Net Income
No data available :(
GBIO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 264.4 million | - | 97.9 million |
| 2023-09-30 | 291.0 million | - | 79.7 million |
| 2023-06-30 | 314.1 million | - | 80.6 million |
| 2023-03-31 | 288.6 million | - | 82.4 million |
GBIO Shares Outstanding
GBIO Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 4.6 million | 27.9 million | 13.4 million | - |
| 2023-09-30 | 610000 | 21.9 million | 11.6 million | - |
| 2023-06-30 | 1.5 million | 21.8 million | 13.0 million | - |
| 2023-03-31 | 755000 | 22.0 million | 12.9 million | - |
GBIO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 2.9 million | 2.0 million |
| 2023-09-30 | 2.1 million | 1.3 million |
| 2023-06-30 | 880000 | 1.3 million |
| 2023-03-31 | - | 1.3 million |
GBIO
Price: $3.35
52 week price:
Earnings Per Share: -1.96 USD
P/E Ratio: -0.93
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 16029
Market Capitalization: 210.8 million